Contrasting Editas Medicine (EDIT) & The CompetitionDispatch TribunalCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1),… Continue reading
Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergenDove Medical PressAbstract: Immunotherapy by sublingual administration of allergens provides high patient compliance and has emerged as an alternative to subcutaneou… Continue reading
Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergenDove Medical PressAbstract: Immunotherapy by sublingual administration of allergens provides high patient compliance and has emerged as an alternative to subcutaneou… Continue reading
BBC News |
Why I injected myself with an untested gene therapy
BBC News The moment Tristan Roberts became the first human to inject an untested, experimental gene therapy into his stomach fat, he was sitting on a leather couch in his friend-slash-yoga instructor’s living room, not on a doctor’s examining table. The glass … |
Business Wire (press release) |
US Stem Cell Responds to FDA’s Regenerative Medicine Guidelines
Business Wire (press release) It also includes regulatory guidance for off-the-shelf products that, due to their construct, require complex, lengthy and expensive entries to market, since they can involve using modified, third-party stem cells, which can require intense FDA … |
|
US Stem Cell Responds to FDA’s Regenerative Medicine Guidelines
Business Wire (press release) SUNRISE, Fla.–(BUSINESS WIRE)–U.S. Stem Cell, Inc. (OTC: USRM), a leader in development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today responded to the recently-announced Food and Drug … Challenges of stem cell therapy for cancer | SunStarSun.Star McGill hosts speakers on the ethical and legal ramifications of stem cell researchMcGill Tribune Modified blood stem cells reverse type 1 diabetes in miceDiabetes.co.uk BioNews –Digital Journal –Medgadget (blog) all 26 news articles » |
Cancer Therapy Advisor |
Alexander Lesokhin, MD, on the Potential of Immunotherapy for Myeloma
Cancer Therapy Advisor Cancer Therapy Advisor’s Jonathan Goodman interviews Alexander Lesokhin, MD, a hematologic oncologist at Memorial Sloan Kettering Cancer Center in New York, New York, who specializes in treating patients with multiple myeloma. Click below to watch … |